Vida Ventures Advisors »

Kyverna Therapeutics shares owned by Vida Ventures Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Vida Ventures Advisors from 13F filings

Historical chart of Vida Ventures Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Vida Ventures Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Vida Ventures Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $112M 4.5M 24.84

More positions owned by Vida Ventures Advisors

Kyverna Therapeutics Common Stock
Centessa Pharmaceuticals Ordinary Shares (CNTA)
Dyne Therapeutics Common Stock (DYN)
Allogene Therapeutics Common Stock (ALLO)
Kronos Bio Common Stock (KRON)

View all positions for Vida Ventures Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics